|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 126, Issue 23 5327-5337, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
G Kumano, L Belluzzi and WC Smith
Department of Molecular, Cellular and Developmental Biology, and Neuroscience Research Institute, University of California, Santa Barbara, CA 93106, USA.
Questions of dorsoventral axis determination and patterning in Xenopus seek to uncover the mechanisms by which particular mesodermal fates, for example somite, are specified in the dorsal pole of the axis while other mesoderm fates, for example, ventral blood island (VBI), are specified at the ventral pole. We report here that the genes Xvent-1, Xvent-2, and Xwnt-8 do not appear to be in the pathway of VBI induction, contrary to previous reports. Results from the selective inhibition of bone morphogenetic protein (BMP) activity, a key regulator of VBI induction, by ectopic Noggin, Chordin, or dominant negative BMP ligands and receptors suggest an alternative route of VBI induction. Injection of noggin or chordin RNA into animal pole blastomeres effectively inhibited VBI development, while marginal zone injection had no effect. Cell autonomous inhibition of BMP activity in epidermis with dominant negative ligand dramatically reduced the amount of (&agr;)T3 globin expression. These results indicate that signaling activity from the Spemann Organizer alone may not be sufficient for dorsoventral patterning in the marginal zone and that an inductive interaction between presumptive VBIs and ectoderm late in gastrulation may be crucial. In agreement with these observations, other results show that in explanted blastula-stage marginal zones a distinct pattern develops with a restricted VBI-forming region at the vegetal pole that is independent of the patterning activity of the Spemann Organizer.
This article has been cited by other articles:
|
|
 |
|
  M. Walmsley, D. Cleaver, and R. Patient Fibroblast growth factor controls the timing of Scl, Lmo2, and Runx1 expression during embryonic blood development Blood, February 1, 2008; 111(3): 1157 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schmerer, I. Torregroza, A. Pascal, M. Umbhauer, and T. Evans STAT5 acts as a repressor to regulate early embryonic erythropoiesis Blood, November 1, 2006; 108(9): 2989 - 2997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gupta, H. Zhu, L. I. Zon, and T. Evans BMP signaling restricts hemato-vascular development from lateral mesoderm during somitogenesis Development, June 1, 2006; 133(11): 2177 - 2187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Goldman, L. K. Berg, M. C. Heinrich, and J. L. Christian Ectodermally derived steel/stem cell factor functions non-cell autonomously during primitive erythropoiesis in Xenopus Blood, April 15, 2006; 107(8): 3114 - 3121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Sadlon, I. D. Lewis, and R. J. D'Andrea BMP4: Its Role in Development of the Hematopoietic System and Potential as a Hematopoietic Growth Factor Stem Cells, July 1, 2004; 22(4): 457 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schmerer and T. Evans Primitive erythropoiesis is regulated by Smad-dependent signaling in postgastrulation mesoderm Blood, November 1, 2003; 102(9): 3196 - 3205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Walmsley, A. Ciau-Uitz, and R. Patient Adult and embryonic blood and endothelium derive from distinct precursor populations which are differentially programmed by BMP in Xenopus Development, March 14, 2003; 129(24): 5683 - 5695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Walters, G. A. Wayman, J. C. Notis, R. H. Goodman, T. R. Soderling, and J. L. Christian Calmodulin-dependent protein kinase IV mediated antagonism of BMP signaling regulates lineage and survival of hematopoietic progenitors Development, March 5, 2003; 129(6): 1455 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Collavin and M. W. Kirschner The secreted Frizzled-related protein Sizzled functions as a negative feedback regulator of extreme ventral mesoderm Development, February 15, 2003; 130(4): 805 - 816. [Abstract] [Full Text] [PDF]
|
|
